Dyslipidemia, characterized by a high level of lipids (cholesterol, triglycerides, or both), can
increase the risk of developing and progressing atherosclerosis. As atherosclerosis …

Future work should prioritize the adequate representation of women in HIV clinical studies.
Understanding sex-specific mechanisms underlying metabolic dysfunction in PWH is …

Background Antiretroviral therapy (ART) improved the prognosis of people living with human
immunodeficiency virus (HIV)(PLWH). Life-long treatment is required in PLWH and is …

Background Anti-retroviral treatment has improved mortality of human immunodeficiency
virus (HIV) infected patients, which is offset by an increasing burden of cardiovascular …

Background Despite its importance as a major risk factor for cardiovascular disease,
dyslipidemia remains poorly characterized in the African population. Objective To assess the …

Background Dyslipidemia is a common public health problem in Africa. It has emerged as an
important cardiovascular risk factor. It has been steadily increasing due to economic growth …

Background Cardiometabolic diseases are a leading cause of HIV-related morbidity and
mortality, yet routine screening is not undertaken in high-burden countries. We aimed to …

Objective To investigate the protective effect of the of Valeriana officinalis L. extract on
mitochondrial injury in AS mice and the underlying mechanism. Methods Firstly, Ultra-High …

Introduction Dyslipidemia is a common public health problem in people living with human
immunodeficiency virus (HIV) who are receiving antiretroviral therapy and increases the risk …

Background Dyslipidemia is responsible for more than half of the global ischemic heart
disease (IHD) and more than 4 million deaths annually. Assessing the prevalence of …